Germany
Japan
United Kingdom
China
Mouse Monoclonal TLR4 Antibody (76B357.1)
| Applications | Block/Neutralize, ChIP, CyTOF-ready, Dot, ELISA, FC, ICC/IF, IHC, SDS-PAGE, WB |
| Reactivities | Human, Mouse, Rat, Squirrel |
| Conjugation | Unconjugated |
Primary Antibodies
View as table Download
Rabbit Polyclonal Calreticulin Antibody
| Applications | Block/Neutralize, Dot, Electron Microscopy, FC, ICC/IF, IHC, IP, Protein Array, Simple Western, WB |
| Reactivities | Human, Mouse, Rat, Bovine, Hamster, Primate |
| Conjugation | Unconjugated |
| Immunogen | A fusion protein to mouse Calreticulin [UniProt# P14211] |
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human (Predicted: Mouse, Rat, Drosophila) |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
Rabbit Polyclonal GLP-1R Antibody
| Applications | Dot, ICC/IF, IHC, Simple Western, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to an internal portion of the human GLP1R protein (between residues 250-350) [UniProt P43220] |
Rabbit Polyclonal TLR7 Antibody
| Applications | Dot, FC, ICC/IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | This antibody was developed against KLH-conjugated synthetic peptide corresponding to amino acids 706-749 of human TLR7; GenBank no. gb|AAF78035.1|AF245702_1. It will cross-react with mouse TLR7. In human Ramos cells, additional bands are seen. |
Rabbit Polyclonal TLR1 Antibody
| Applications | Dot, FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | This antibody was developed against a KLH-conjugated synthetic peptide corresponding to a sequence within amino acids 400-450 of human TLR1. |
Rabbit Polyclonal TLR3 Antibody
| Applications | Dot, FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | A mix of synthetic peptides corresponding to amino acids 135-150 (SIHKIKSNPFKNQKNL), 828-844 (CRRFKVHHAVQQAIEQN), and 876-891 (CILNWPVQKERINAFH) of mouse TLR3. |
Mouse Monoclonal TLR2 Antibody (TL2.1)
| Applications | Block/Neutralize, Dot, ELISA, FC, ICC/IF, IP, WB |
| Reactivities | Human, Canine |
| Conjugation | Unconjugated |
TA336462 is a replacement of TA320480.
Rabbit polyclonal Phospho-EGFR(Y1172) Antibody
| Applications | Dot, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This EGFR Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding Y1172 of human EGFR. |
| Modifications | Phospho-specific |
USD 605.00
5 Days
Rabbit polyclonal Phospho-cJun(S63) Antibody
| Applications | Dot, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This cJun Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding S63 of human cJun. |
| Modifications | Phospho-specific |
Active filters
Reactivities
- Human
Applications
- Dot
Families
- Druggable Genome
Filter by
Category
Target Symbol
- RON (5)
- HER2 (4)
- CTNND1 (3)
- IRS1 (3)
- JAK2 (3)
- ANDROGEN RECEPTOR (2)
- BCAR3 (2)
- C-JUN (2)
- CDC2 (2)
- IRS2 (2)
- MEK5 (2)
- NEUROFIBROMIN (2)
- NEUROPILIN 1 (2)
- PTEN (2)
- SOX9 (2)
- STAT1 (2)
- STAT3 (2)
- AKT1 (1)
- AMYLOID PRECURSOR PROTEIN (1)
- BCL2 (1)
- CALRETICULIN (1)
- CDK7 (1)
- CREB1 (1)
- EGFR (1)
- ERK1 (1)
- GLP1R (1)
- H2A.Z (1)
- HISTONE H2A.X (1)
- INSULIN (1)
- IRAK4 (1)
- LRP5 (1)
- LRP6 (1)
- OCT-1 (1)
- P53 (1)
- RHOA (1)
- STAT4 (1)
- TAPA1 (1)
- TLR1 (1)
- TLR2 (1)
- TLR3 (1)
- TLR4 (1)
- TLR5 (1)
- TLR7 (1)
- TLR9 (1)
Antibody Hosts
Clonalities
Conjugates
Modifications
Assay Types
Pathways
- Pathways in cancer (20)
- Neurotrophin signaling pathway (15)
- Prostate cancer (15)
- Toll-like receptor signaling pathway (14)
- Focal adhesion (13)
- Pancreatic cancer (12)
- Adipocytokine signaling pathway (11)
- Adherens junction (10)
- Chemokine signaling pathway (10)
- Endometrial cancer (10)
- MAPK signaling pathway (10)
- ErbB signaling pathway (9)
- Jak-STAT signaling pathway (9)
- Insulin signaling pathway (8)
- Non-small cell lung cancer (8)
- Bladder cancer (7)
- Colorectal cancer (7)
- Type II diabetes mellitus (7)
- Gap junction (6)
- Glioma (6)
- Melanoma (6)
- Oocyte meiosis (6)
- Wnt signaling pathway (6)
- B cell receptor signaling pathway (5)
- Calcium signaling pathway (5)
- Progesterone-mediated oocyte maturation (5)
- Small cell lung cancer (5)
- T cell receptor signaling pathway (5)
- p53 signaling pathway (5)
- Acute myeloid leukemia (4)
- Apoptosis (4)
- Axon guidance (4)
- Cell cycle (4)
- GnRH signaling pathway (4)
- Leukocyte transendothelial migration (4)
- Regulation of actin cytoskeleton (4)
- Renal cell carcinoma (4)
- Tight junction (4)
- Chronic myeloid leukemia (3)
- Epithelial cell signaling in Helicobacter pylori infection (3)
- Pathogenic Escherichia coli infection (3)
- mTOR signaling pathway (3)
- Alzheimer's disease (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Antigen processing and presentation (2)
- Dorso-ventral axis formation (2)
- Fc epsilon RI signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Huntington's disease (2)
- Inositol phosphate metabolism (2)
- Melanogenesis (2)
- Phosphatidylinositol signaling system (2)
- Systemic lupus erythematosus (2)
- TGF-beta signaling pathway (2)
- Thyroid cancer (2)
- VEGF signaling pathway (2)
- Vascular smooth muscle contraction (2)
- Basal cell carcinoma (1)
- Cytokine-cytokine receptor interaction (1)
- Endocytosis (1)
- Long-term depression (1)
- Long-term potentiation (1)
- Maturity onset diabetes of the young (1)
- NOD-like receptor signaling pathway (1)
- Natural killer cell mediated cytotoxicity (1)
- Neuroactive ligand-receptor interaction (1)
- Nucleotide excision repair (1)
- Prion diseases (1)
- Regulation of autophagy (1)
- Type I diabetes mellitus (1)